ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L01EA01 | G | Imatinib - 400mg | 7397 | 166541/11 | CEMIVIL | 400mg | 30 | Tablet, film coated | Oral | Abela Frères S.A.L. | The Arab Pharmaceutical Manufacturing PSC | Jordan | 41,163,099 L.L | 10.71 | E1 | Hikma Pharmaceuticals | Jordan | 2/5/2024 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L01EA01 | G | Imatinib (mesylate) - 400mg | 8210 | 185820/13 | GLIMATINIB BENTA 400 | 400mg | 30 | Tablet, film coated | Oral | Benta Trading Co s.a.l. | Benta SAL | Lebanon | 38,254,090 L.L | 10.71 | E1 | 2/5/2024 | 0 | ||
L01EA01 | G | Imatinib - 400mg | 10952 | 136921/1 | IMATINIB GP PHARM | 400mg | 30 | Tablet, coated | Oral | Mediterranean Pharmaceutical Company | GP-Pharm, SA | Argentine | 26,083,945 L.L | 19.35 | D | GP-Pharm, SA | Argentine | 2/5/2024 | 0 |
L01EA01 | G | Imatinib - 400mg | 10956 | 90922/1 | IMATINIB NEAPOLIS | 400mg | 30 | Tablet, film coated | Oral | Medis Pharm Drugstore | Neapolis Pharma | Tunisia | 36,046,335 L.L | 19.35 | D | Neapolis Pharma | Tunisia | 2/5/2024 | 0 |
L01EA01 | G | Imatinib - 400mg | 11264 | 6521/1 | IMATINIB SPC | 400mg | 30 | Tablet, film coated | Oral | Advanced Healthcare Services SAL | Pharmaline SAL Licensed by Sudair Pharma Company, KSA | Lebanon | 62,161,280 L.L | 10.71 | E1 | 2/5/2024 | 0 | ||
L01EA01 | G | Imatinib - 400mg | 7294 | 187474/13 | SAGITTA | 400mg | 30 | Capsule, hard | Oral | Raymond Georges Abou Adal & Co | Adamed Pharma S.A., Pabianice, Poland, for Arwan Pharmaceutical industries Lebanon SAL | Lebanon | 51,723,840 L.L | 10.71 | E1 | 2/5/2024 | 0 |